Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00705523 · ClinicalTrials.gov registry record · Phase 2
Varenicline (Chantix™) for the Treatment of Alcohol Dependence
A Phase 2 study, sponsored by University of Pennsylvania.
- Completed
- Registry status
- Phase 2
- Development phase
- 40
- Enrollment target
NCT00705523: Completed Phase 2 study, sponsored by University of Pennsylvania.
NCT00705523 is a Phase 2 study that has completed, run by University of Pennsylvania. The registered enrollment target is 40 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00705523, a Phase 2 study, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 40 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the efficacy of varenicline (Chantix™) for the treatment of alcohol dependence.
Interventions
- DRUG placebo
- DRUG varenicline
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2008-06 |
| Est. Completion | 2011-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00705523
The ClinicalTrials.gov registry entry for NCT00705523 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which placebo is the first listed.
NCT00705523 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00705523 about?
NCT00705523 is a clinical study titled "Varenicline (Chantix™) for the Treatment of Alcohol Dependence". The purpose of this study is to determine the efficacy of varenicline (Chantix™) for the treatment of alcohol dependence.
What is the current status of trial NCT00705523?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 40 participants. The study started on 2008-06. Estimated completion is 2011-12.
What interventions are being tested in trial NCT00705523?
The interventions under investigation include: placebo (DRUG), varenicline (DRUG).
Who is sponsoring clinical trial NCT00705523?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.